Encompass Health CORP Form 4 insider transactions

NYSE
Terrance Williams, a director at Encompass Health Corp, acquired 21 shares of common stock due to a dividend reinvestment program.
NYSE
Director Nancy M. Schlichting reports the acquisition of 33 restricted stock units (RSUs) of Encompass Health Corp due to a dividend payment, increasing her total holdings to 17,611 shares.
NYSE
Director Christopher R. Reidy increased his holdings in Encompass Health Corp through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.
NYSE
Kevin J. O'Connor, a director of Encompass Health Corp, reported the acquisition of 11 restricted stock units (RSUs) due to a dividend payment on April 15, 2024.
NYSE
Patricia Anne Maryland, a director at Encompass Health Corp, received 21 additional restricted stock units (RSUs) due to a dividend payment on April 15, 2024.
NYSE
Leslye G. Katz, a director of Encompass Health Corp, acquired 80 restricted stock units (RSUs) as a result of a dividend payment on April 15, 2024.
NYSE
Director Joan E. Herman reports acquiring 80 shares of Encompass Health Corp through a dividend reinvestment program.
NYSE
Director Donald L. Correll acquired 184 shares of Encompass Health Corp through a dividend reinvestment program.
NYSE
Director Greg D. Carmichael acquired 21 additional restricted stock units (RSUs) in Encompass Health Corp due to a dividend payment on April 15, 2024.
NYSE
Director John Chidsey reports acquisition of Encompass Health common stock through dividend reinvestment and deferred stock investment plan.
NYSE
Encompass Health Corp's CEO, Mark J. Tarr, received non-qualified stock options exercisable over three years starting March 1, 2025.
NYSE
Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reported the grant of non-qualified stock options exercisable over three years, commencing March 1, 2025.
NYSE
John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports acquisition of non-qualified stock options exercisable over three years.
NYSE
Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, reports acquisition of shares through restricted stock issuance and annual award.
NYSE
Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports the acquisition of shares of restricted stock due to performance criteria and an annual award.
NYSE
John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports acquiring shares of common stock through restricted stock issuances.
NYSE
Douglas Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports acquisition of shares through restricted stock awards.
NYSE
Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports acquisition of shares through restricted stock awards.
NYSE
Encompass Health Corp's CEO, Mark Tarr, reports acquiring shares of common stock through restricted stock awards.